Big Pharma accused of 'endless talk, no action' on antibiotic threat

Former head of UK review has also called for a new government-utility-type drug company

The pharmaceutical industry should match its words with action on researching new antibiotics to address the threat posed by drug-resistant superbugs, a former UK Government adviser says.